<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39462048</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>HbA1c and leukocyte mtDNA levels as major factors associated with post-COVID-19 syndrome in type 2 diabetes patients.</ArticleTitle><Pagination><StartPage>25533</StartPage><MedlinePgn>25533</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">25533</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-77496-2</ELocationID><Abstract><AbstractText>Post-COVID-19 syndrome (PCS) is an emerging health problem in people recovering from COVID-19 infection within the past 3-6 months. The current study aimed to define the predictive factors of PCS development by assessing the mitochondrial DNA (mtDNA) levels in blood leukocytes, inflammatory markers and HbA1c in type 2 diabetes patients (T2D) with regard to clinical phenotype, gender, and biological age. In this case-control study, 65 T2D patients were selected. Patients were divided into 2 groups depending on PCS presence: the PCS group (n = 44) and patients who did not develop PCS (n = 21) for up to 6 months after COVID-19 infection. HbA1c and mtDNA levels were the primary factors linked to PCS in different models. We observed significantly lower mtDNA content in T2D patients with PCS compared to those without PCS (1.26 ± 0.25 vs. 1.44 ± 0.24; p = 0.011). In gender-specific and age-related analyses, the mt-DNA amount did not differ significantly between the subgroups. According to the stepwise multivariate logistic regression analysis, low mtDNA content and HbA1c were independent variables associated with PCS development, regardless of oxygen, glucocorticoid therapy and COVID-19 severity. The top-performing model for PCS prediction was the gradient boosting machine (GBM). HbA1c and mtDNA had a notably greater influence than the other variables, indicating their potential as prognostic biomarkers.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matviichuk</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Endocrinology Department, Bogomolets National Medical University, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yerokhovych</LastName><ForeName>Viktoriia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Endocrinology Department, Bogomolets National Medical University, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ilkiv</LastName><ForeName>Yeva</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Endocrinology Department, Bogomolets National Medical University, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krasnienkov</LastName><ForeName>Dmytro</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Laboratory of Epigenetics, Institute of Gerontology Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Blackthorn AI, Ltd, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Korcheva</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory of Epigenetics, Institute of Gerontology Academy of Medical Sciences of Ukraine, Kyiv, Ukraine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurbych</LastName><ForeName>Oleksandr</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Blackthorn AI, Ltd, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Lviv Polytechnic National University, Lviv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shcherbakova</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Laboratory CSD, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botsun</LastName><ForeName>Pavlina</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Laboratory CSD, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falalyeyeva</LastName><ForeName>Tetyana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Laboratory CSD, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sulaieva</LastName><ForeName>Oksana</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Medical Laboratory CSD, Kyiv, Ukraine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kyiv Medical University, Kyiv, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobyliak</LastName><ForeName>Nazarii</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Endocrinology Department, Bogomolets National Medical University, Kyiv, Ukraine. nazariikobyliak@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Laboratory CSD, Kyiv, Ukraine. nazariikobyliak@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctor of Medicine, Endocrinology Department, Bogomolets National Medical University, Ievgena Chykalenka 22a str, Kyiv, 01601, Ukraine. nazariikobyliak@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021.01/0213</GrantID><Agency>National Research Foundation of Ukraine</Agency><Country /></Grant><Grant><GrantID>2021.01/0213</GrantID><Agency>National Research Foundation of Ukraine</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006442">Glycated Hemoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C517652">hemoglobin A1c protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="Y">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006442" MajorTopicYN="Y">Glycated Hemoglobin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="Y">Leukocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>7</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>7</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39462048</ArticleId><ArticleId IdType="pmc">PMC11513135</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-77496-2</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-77496-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Falalyeyeva, T. et al. Vitamin D in the prevention and treatment of type-2 diabetes and associated diseases: a critical view during COVID-19 time. Minerva Biotechnol. Biomol. Res.33, (2021).</Citation></Reference><Reference><Citation>Frutos, R., Gavotte, L., Serra-Cobo, J., Chen, T. &amp; Devaux, C. COVID-19 and emerging infectious diseases: the society is still unprepared for the next pandemic. Environ. Res.202, 111676 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8268624</ArticleId><ArticleId IdType="pubmed">34252435</ArticleId></ArticleIdList></Reference><Reference><Citation>Petakh, P., Kobyliak, N. &amp; Kamyshnyi, A. Gut microbiota in patients with COVID-19 and type 2 diabetes: a culture-based method. Front. Cell. Infect. Microbiol.13, 1142578 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9947359</ArticleId><ArticleId IdType="pubmed">36844398</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal, J. et al. High prevalence of post COVID-19 fatigue in patients with type 2 diabetes: a case-control study. Diabetes Metabolic Syndrome. 15, 102302 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462068</ArticleId><ArticleId IdType="pubmed">34626924</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhowal, C., Ghosh, S., Ghatak, D. &amp; De, R. Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight. Mol. Cell. Biochem.478, 1325–1343 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9617539</ArticleId><ArticleId IdType="pubmed">36308668</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh, J., Peyssonnaux, C., Singh, K. K. &amp; Edeas, M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 54, 1–7 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837003</ArticleId><ArticleId IdType="pubmed">32574708</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdés-Aguayo, J. J. et al. Mitochondria and mitochondrial DNA: key elements in the Pathogenesis and exacerbation of the inflammatory state caused by COVID-19. Med. (Kaunas Lithuania). 57, 928 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8471487</ArticleId><ArticleId IdType="pubmed">34577851</ArticleId></ArticleIdList></Reference><Reference><Citation>Potus, F. et al. Novel insights on the pulmonary vascular consequences of COVID-19. Am. J. Physiol. Lung Cell. Mol. Physiol.319, L277–L288 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414237</ArticleId><ArticleId IdType="pubmed">32551862</ArticleId></ArticleIdList></Reference><Reference><Citation>Melchinger, H., Jain, K., Tyagi, T. &amp; Hwa, J. Role of platelet mitochondria: life in a nucleus-free zone. Front. Cardiovasc. Med.6, 153 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6828734</ArticleId><ArticleId IdType="pubmed">31737646</ArticleId></ArticleIdList></Reference><Reference><Citation>Streng, L. W. J. M. et al. In vivo and Ex vivo mitochondrial function in COVID-19 patients on the Intensive Care Unit. Biomedicines. 10, 7161 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9313105</ArticleId><ArticleId IdType="pubmed">35885051</ArticleId></ArticleIdList></Reference><Reference><Citation>Medini, H., Zirman, A. &amp; Mishmar, D. Immune system cells from COVID-19 patients display compromised mitochondrial-nuclear expression co-regulation and rewiring toward glycolysis. iScience. 24, 103471 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8599136</ArticleId><ArticleId IdType="pubmed">34812416</ArticleId></ArticleIdList></Reference><Reference><Citation>Faizan, M. I. et al. NSP4 and ORF9b of SARS-CoV-2 induce pro-inflammatory mitochondrial DNA release in inner membrane-derived vesicles. Cells. 11, 2969 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9561960</ArticleId><ArticleId IdType="pubmed">36230930</ArticleId></ArticleIdList></Reference><Reference><Citation>Andargie, T. E. et al. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight. 6, e147610 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8119224</ArticleId><ArticleId IdType="pubmed">33651717</ArticleId></ArticleIdList></Reference><Reference><Citation>Edinger, F. et al. Peak plasma levels of mtDNA serve as a predictive biomarker for COVID-19 in-hospital mortality. J. Clin. Med.11, 7161 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9740249</ArticleId><ArticleId IdType="pubmed">36498735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoodpoor, A. et al. Prognostic potential of circulating cell free mitochondrial DNA levels in COVID-19 patients. Mol. Biol. Rep.50, 10249–10255 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37934373</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann, H. et al. Markers of oxidative stress during post-COVID-19 fatigue: a hypothesis-generating, exploratory pilot study on hospital employees. Front. Med.10, 1305009 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10725950</ArticleId><ArticleId IdType="pubmed">38111693</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson, B. A. et al. Plasma proteomics show altered inflammatory and mitochondrial proteins in patients with neurologic symptoms of post-acute sequelae of SARS-CoV-2 infection. Brain. Behav. Immun.114, 462–474 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10718560</ArticleId><ArticleId IdType="pubmed">37704012</ArticleId></ArticleIdList></Reference><Reference><Citation>Living guidance for clinical management of COVID-19. October (2024). https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2. (Accessed: 3rd.</Citation></Reference><Reference><Citation>Barrea, L. et al. Vitamin D: a role also in long COVID-19? Nutrients. 14, 1625 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9028162</ArticleId><ArticleId IdType="pubmed">35458189</ArticleId></ArticleIdList></Reference><Reference><Citation>Scozzi, D. et al. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 6, e143299 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934921</ArticleId><ArticleId IdType="pubmed">33444289</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoraka, S., Mohebbi, S. R., Hosseini, S. M. &amp; Zali, M. R. Comparison of plasma mitochondrial DNA copy number in asymptomatic and symptomatic COVID-19 patients. Front. Microbiol.14, 1256042 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10587688</ArticleId><ArticleId IdType="pubmed">37869674</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdés-Aguayo, J. J. et al. Peripheral blood mitochondrial DNA levels were modulated by SARS-CoV-2 infection severity and its lessening was Associated with Mortality among hospitalized patients with COVID-19. Front. Cell. Infect. Microbiol.11, 754708 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8716733</ArticleId><ArticleId IdType="pubmed">34976854</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakes, F. M. &amp; Van Houten, B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U.S.A.94, 514–519 (1997).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19544</ArticleId><ArticleId IdType="pubmed">9012815</ArticleId></ArticleIdList></Reference><Reference><Citation>Croteau, D. L., Stierum, R. H. &amp; Bohr, V. A. Mitochondrial DNA repair pathways. Mutat. Res.434, 137–148 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10486588</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai, D. F., Rabinovitch, P. S. &amp; Ungvari, Z. Mitochondria and cardiovascular aging. Circul. Res.110, 1109–1124 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3867977</ArticleId><ArticleId IdType="pubmed">22499901</ArticleId></ArticleIdList></Reference><Reference><Citation>Boengler, K., Heusch, G. &amp; Schulz, R. Nuclear-encoded mitochondrial proteins and their role in cardioprotection. Biochim. Biophys. Acta. 1813, 1286–1294 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21255616</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, D. X. Mitochondrial dysfunction, a weakest link of network of aging, relation to innate intramitochondrial immunity of DNA recognition receptors. Mitochondrion. 76, 101886 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38663836</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangalhara, K. C. &amp; Shadel, G. S. A mitochondrial-derived peptide exercises the Nuclear option. Cell Metabol.28, 330–331 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30184481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfanner, N., Warscheid, B. &amp; Wiedemann, N. Mitochondrial proteins: from biogenesis to functional networks. Nat. Rev. Mol. Cell Biol.20, 267–284 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6684368</ArticleId><ArticleId IdType="pubmed">30626975</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti, P., Ilamathi, H. S., Todkar, K. &amp; Germain, M. Mitochondria targeted viral replication and survival strategies-prospective on SARS-CoV-2. Front. Pharmacol.11, 578599 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7485471</ArticleId><ArticleId IdType="pubmed">32982760</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa, T. J. et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vascul. Pharmacol.142, 106946 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8612754</ArticleId><ArticleId IdType="pubmed">34838735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. &amp; McLean, A. S. The role of Mitochondria in the Immune response in critical illness. Crit. Care. (London, England). 26, 80 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8957137</ArticleId><ArticleId IdType="pubmed">35337333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimalawansa, S. J. &amp; Vitamin, D. deficiency: Effects on oxidative stress, epigenetics, gene regulation, and aging. Biology 8, 30 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6627346</ArticleId><ArticleId IdType="pubmed">31083546</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo, L. et al. Low vitamin D levels are Associated with Long COVID Syndrome in COVID-19 survivors. J. Clin. Endocrinol. Metab.108, e1106–e1116 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="pubmed">37051747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, T. et al. COVID-19 metabolism: mechanisms and therapeutic targets. MedComm. 3, e157 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9363584</ArticleId><ArticleId IdType="pubmed">35958432</ArticleId></ArticleIdList></Reference><Reference><Citation>Merzon, E. et al. Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes. Diab./Metab. Res. Rev.37, e3398 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7460936</ArticleId><ArticleId IdType="pubmed">32852883</ArticleId></ArticleIdList></Reference><Reference><Citation>Belsky, D. W. et al. Quantification of biological aging in young adults. Proc. Natl. Acad. Sci. U.S.A.112, E4104–E4110 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4522793</ArticleId><ArticleId IdType="pubmed">26150497</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood, E., Hall, K. H. &amp; Tate, W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: a possible approach to SARS-CoV-2 ‘long-haulers’? Chronic Dis. Translational Med.7, 14–26 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, I. et al. Persistent Exertional Intolerance after COVID-19: insights from Invasive Cardiopulmonary Exercise Testing. Chest. 161, 54–63 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical management of COVID-19. https://www.who.int/teams/health-care-readiness/covid-19. (Accessed: 27th March 2024).</Citation></Reference><Reference><Citation>Hegazy, M. A. et al. COVID-19 Disease outcomes: does gastrointestinal Burden play a role? Clin. Exp. Gastroenterol.14, 199–207 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8164348</ArticleId><ArticleId IdType="pubmed">34079323</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick, M. F. et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab.96, 1911–1930 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21646368</ArticleId></ArticleIdList></Reference><Reference><Citation>Aludwan, M. et al. Vitamin D3 deficiency is associated with more severe insulin resistance and metformin use in patients with type 2 diabetes. Minerva Endocrinol.45, 172–180 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33000618</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh, A. Y. Y., Budd, M., Deng, D., Gadawska, I. &amp; Côté, H. C. F. A monochrome Multiplex Real-Time quantitative PCR assay for the measurement of mitochondrial DNA content. J. Mol. Diagnostics: JMD. 20, 612–620 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29936256</ArticleId></ArticleIdList></Reference><Reference><Citation>Guescini, M., Sisti, D., Rocchi, M. B. L., Stocchi, L. &amp; Stocchi, V. A new real-time PCR method to overcome significant quantitative inaccuracy due to slight amplification inhibition. BMC Bioinform.9, 326 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2533027</ArticleId><ArticleId IdType="pubmed">18667053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mykhalchyshyn, G., Kobyliak, N. &amp; Bodnar, P. Diagnostic accuracy of acyl-ghrelin and it association with non-alcoholic fatty liver disease in type 2 diabetic patients. J. Diabetes Metab. Disord.14, (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4438435</ArticleId><ArticleId IdType="pubmed">25995986</ArticleId></ArticleIdList></Reference><Reference><Citation>7th ICML Workshop on Automated Machine Learning. AutoML (2020). https://icml.cc/virtual/2020/workshop/5725. (Accessed: 17th May 2024).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>